CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07038200
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:36.508433+00:00
Published At: 2026-01-20T00:00:00+00:00
Record Updated At: 2026-01-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Facioscapulohumeral Muscular Dystrophy", "FSHD", "FSHD - Facioscapulohumeral Muscular Dystrophy", "FSHD1", "FSHD2", "Fascioscapulohumeral Muscular Dystrophy", "Fascioscapulohumeral Muscular Dystrophy Type 1", "Fascioscapulohumeral Muscular Dystrophy Type 2", "Facioscapulohumeral Muscular Dystrophy 1", "Facioscapulohumeral Dystrophy", "Facio-Scapulo-Humeral Dystrophy", "Facioscapulohumeral Muscular Dystrophy 2", "Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)", "FSH Muscular Dystrophy", "Landouzy Dejerine Dystrophy", "Landouzy-Dejerine Muscular Dystrophy", "Landouzy-Dejerine Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-01-20"
protocolSection.identificationModule.nctId: "NCT07038200"
protocolSection.identificationModule.officialTitle: "A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.